查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519468

2024-2032 年按生物标记类型、诊断技术、最终用户和地区分類的肾臟生物标记市场报告

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球肾臟生物标记市场规模达到13亿美元。

肾臟生物标记是尿液分析中存在的细胞、蛋白质、脂质、microRNA、基因、代谢物或蛋白质体模式。它们有助于确定肾臟的肾小球滤过率 (GFR)，以分析其正常功能并评估致病过程或对治疗介入的药理反应。由于肾臟生物标记也有助于预测疾病进展和计算药物剂量，因此它们在全球的医院和诊断实验室中得到了广泛的应用。

肾臟生物标记市场趋势：

慢性肾臟病（CKD）是一种发病率和死亡率较高的非传染性疾病，已逐渐成为全球关注的公共卫生问题，其主要危险因子是糖尿病、高血压和心臟病。慢性肾臟病患者数量的增加是推动市场成长的关键因素之一。此外，肾臟生物标记，包括血中尿素氮（BUN）、血清肌酸酐（SCr）、尿液白蛋白/蛋白和容量排泄，用于慢性肾臟病（CKD）的诊断和疾病监测。除此之外，产业投资者对世界各地人类肾臟疾病的新型单一生物标记和特定过程的生物标记组合越来越感兴趣。这些新型生物标记提供重要的诊断和预后讯息，并有助于预测肾丝球病变、急性肾损伤 (AKI) 和常染色体显性多囊性肾病变 (ADPKD) 的治疗反应。除此之外，肾臟生物标记在各种规模的实验室中变得易于使用和可行。这与基因组学、表观遗传学、转录组学、蛋白质组学和代谢组学的发展和整合一起，正在对市场产生积极影响。其他一些因素，例如蓬勃发展的医疗保健行业、不断增长的老年人口以及全球 CKD 临床试验数量的增加，预计将促进市场的成长。

本报告回答的关键问题

  • 2023年全球肾臟生物标记市场规模有多大？
  • 2024-2032年全球肾臟生物标记市场的预期成长率是多少？
  • COVID-19 对全球肾臟生物标记市场有何影响？
  • 推动全球肾臟生物标记市场的关键因素是什么？
  • 根据生物标记类型，全球肾臟生物标记市场的细分情况如何？
  • 基于诊断技术的全球肾臟生物标记市场的细分情况如何？
  • 基于最终用户的全球肾臟生物标记市场的细分情况如何？
  • 全球肾臟生物标记市场的关键区域有哪些？
  • 谁是全球肾臟生物标记市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肾臟生物标记市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依生物标记类型

  • 功能性生物标记
    • 市场走向
    • 关键环节
      • 血清肌酸酐
      • 血清胱抑素C
      • 尿液白蛋白
    • 市场预测
  • 上调蛋白质
    • 市场走向
    • 关键环节
      • 中性粒细胞明胶酶相关脂质运载蛋白 (NGAL)
      • 肾损伤分子1
      • 白细胞介素18
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：透过诊断技术

  • 酵素连结免疫吸附测定法 (ELISA)
    • 市场走向
    • 市场预测
  • 颗粒增强比浊免疫分析 (PETIA)
    • 市场走向
    • 市场预测
  • 比色测定
    • 市场走向
    • 市场预测
  • 化学发光免疫分析 (CLIA)
    • 市场走向
    • 市场预测
  • 液相层析质谱法 (LC-MS)
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊断实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Beckman Coulter Inc. (Danaher Corporation)
    • bioMerieux SA
    • BioPorto A/S
    • Bio-Rad Laboratories Inc.
    • Enzo Biochem Inc.
    • F. Hoffmann-La Roche AG
    • PerkinElmer Inc.
    • Randox Laboratories Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5273

The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on biomarker type, diagnostic technique and end user.

Breakup by Biomarker Type:

Functional Biomarker

Serum Creatinine

Serum Cystatin C

Urine Albumin

Up-regulated Protein

Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Kidney Injury Molecule-1

INTERLEUKIN-18

Others

Breakup by Diagnostic Technique:

Enzyme-linked Immunosorbent Assay (ELISA)

Particle-enhanced Turbidimetric Immunoassay (PETIA)

Colorimetric Assay

Chemiluminescent Enzyme Immunoassay (CLIA)

Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

Hospital

Diagnostic Laboratory

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global renal biomarkers market in 2023?
  • 2. What is the expected growth rate of the global renal biomarkers market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global renal biomarkers market?
  • 4. What are the key factors driving the global renal biomarkers market?
  • 5. What is the breakup of the global renal biomarkers market based on the biomarker type?
  • 6. What is the breakup of the global renal biomarkers market based on the diagnostic technique?
  • 7. What is the breakup of the global renal biomarkers market based on end user?
  • 8. What are the key regions in the global renal biomarkers market?
  • 9. Who are the key players/companies in the global renal biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomarker Type

  • 6.1 Functional Biomarker
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Serum Creatinine
      • 6.1.2.2 Serum Cystatin C
      • 6.1.2.3 Urine Albumin
    • 6.1.3 Market Forecast
  • 6.2 Up-regulated Protein
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • 6.2.2.2 Kidney Injury Molecule-1
      • 6.2.2.3 INTERLEUKIN-18
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

  • 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colorimetric Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Chemiluminescent Immunoassay (CLIA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BioPorto A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Randox Laboratories Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2023
  • Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2023
  • Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
  • Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
  • Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
  • Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million US$), 2024-2032
  • Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Renal Biomarkers Market: Competitive Structure
  • Table 7: Global: Renal Biomarkers Market: Key Players